tiprankstipranks

New Portfolio - New Portfolio

Alexej Crimotat

New Portfolio
Individual Investor
Ranked #441,890 out of 781,066 TipRanks' Investors
Success Rate
39%
24 out of 61
profitable transactions
Average Return
0.64%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 1.90%
6-Month Return▲ 17.41%
12-Month Return▲ 39.04%
YTD Return▲ 3.65%
Total Return▲ 95.29%

Best Trade

Opened at
Closed at-
Gain▲ 315.52%

Bio

Only for the Brave

Performance

26.04%0-26.04%
▲ 9.79%
▲ 3.53%
▼ 7.32%
Jun 2024
▲ 8.13%
▲ 1.21%
▲ 3.21%
Jul 2024
▼ 13.14%
▲ 2.34%
▼ 1.04%
Aug 2024
▲ 2.93%
▲ 2.10%
▲ 2.62%
Sep 2024
▲ 10.00%
▼ 0.89%
▲ 3.41%
Oct 2024
▲ 26.04%
▲ 5.96%
▲ 12.93%
Nov 2024
▲ 5.93%
▼ 2.41%
▼ 1.64%
Dec 2024
▲ 9.79%
▲ 0.95%
▲ 3.65%
Jan 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 9.79%▲ 3.53%▼ 7.32%
▲ 8.13%▲ 1.21%▲ 3.21%
▼ 13.14%▲ 2.34%▼ 1.04%
▲ 2.93%▲ 2.10%▲ 2.62%
▲ 10.00%▼ 0.89%▲ 3.41%
▲ 26.04%▲ 5.96%▲ 12.93%
▲ 5.93%▼ 2.41%▼ 1.64%
▲ 9.79%▲ 0.95%▲ 3.65%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Novo Nordisk
0%
▼ 4.85%
1
Open
Jan 15, 2025
Eli Lilly & Co
0%
▼ 0.76%
1
Open
Jan 15, 2025
Coinbase Global
16.39%
▲ 24.40%
4
Buy
Dec 29, 2024
Broadcom
11.17%
▲ 0.55%
2
Buy
Dec 28, 2024
ARM Holdings PLC ADR
7.07%
▲ 56.04%
3
Buy
Dec 27, 2024
IMPINJ
8.33%
▼ 10.90%
1
Open
Dec 27, 2024
COMPASS Pathways
2.61%
▼ 36.84%
2
Buy
Dec 19, 2024
Microstrategy
12.53%
▲ 10.32%
2
Buy
Dec 19, 2024
Occidental Petroleum
4.12%
▲ 14.58%
1
Open
Dec 19, 2024
Intellia Therapeutics
1.5%
▼ 26.92%
1
Open
Dec 17, 2024
Abivax SA
0%
▼ 16.10%
1
Open
Dec 17, 2024
MongoDB
4.01%
▲ 3.90%
3
Close
Dec 11, 2024
Alphabet Class A
4.65%
▲ 4.04%
1
Open
Dec 11, 2024
Roku
1.2%
▲ 18.73%
2
Buy
Dec 08, 2024
Avidity Biosciences
2.28%
▲ 147.00%
2
Buy
Dec 08, 2024
Metagenomi, Inc.
2.06%
▼ 57.66%
2
Buy
Dec 08, 2024
Salesforce
2.59%
▲ 28.37%
2
Buy
Dec 08, 2024
Nike
1.13%
▼ 0.77%
2
Buy
Dec 08, 2024
The Estée Lauder Companies
2.49%
▼ 11.32%
2
Buy
Dec 08, 2024
Lululemon Athletica
2.96%
▲ 14.97%
2
Buy
Dec 08, 2024